Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 21st July 2015
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientists repair liver using stem cells
mouse
Liver stem cells were transplanted into mice with liver failure. (stock photo)
Findings bring us "a step closer" to new therapies
 
For the first time, scientists have managed to repair a severely damaged liver using stem cells grown in the laboratory.

It is hoped their findings will lay the foundations for cell-based therapies in the future, which could offer those with liver failure an alternative to organ transplants.

Scientists from the University of Edinburgh transplanted liver stem cells into mice with liver failure. Over several months, they saw major parts of the liver being regrown from these cells, improving its structure and function.

It is the first time researchers have been able to repair the liver to this extent. If the same effect can be demonstrated with human cells this could be a useful treatment for liver failure.

"Revealing the therapeutic potential of these liver stem cells brings us a step closer to developing stem cell based treatments for patients with liver disease," said Professor Stuart Forbes, from the university's Medical Research Council Centre for Regenerative Medicine.

"It will be some time before we can turn this into reality as we will first need to test our approach using human cells. This is much needed as liver disease is a very common cause of death and disability for patients in the UK and the rest of the world.’"

Long-term, the team are hoping to find a way of using medicines to stimulate the patient's own stem cells to repair the damage.

Although the liver has a great capacity to repair itself, conditions such as cirrhosis and liver failure make this impossible.

Hepatocytes within the liver make proteins and break down toxins. They have been used for transplantation before but their use is limited by the fact that they don't grow well under lab conditions.

This can be overcome with liver stem cells as they can be grown in these conditions and can change into hepatocytes and other types of liver cell.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.